Annual CFO
-$124.45 M
+$17.60 M+12.39%
31 December 2023
Summary:
AlloVir annual cash flow from operations is currently -$124.45 million, with the most recent change of +$17.60 million (+12.39%) on 31 December 2023. During the last 3 years, it has fallen by -$63.64 million (-104.65%). ALVR annual CFO is now -6505.10% below its all-time high of $1.94 million, reached on 31 December 2018.ALVR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$8.44 M
+$2.88 M+25.44%
30 September 2024
Summary:
AlloVir quarterly cash flow from operations is currently -$8.44 million, with the most recent change of +$2.88 million (+25.44%) on 30 September 2024. Over the past year, it has increased by +$26.04 million (+75.52%). ALVR quarterly CFO is now -326.86% below its all-time high of -$1.98 million, reached on 31 March 2019.ALVR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$94.87 M
+$26.04 M+21.53%
30 September 2024
Summary:
AlloVir TTM cash flow from operations is currently -$94.87 million, with the most recent change of +$26.04 million (+21.53%) on 30 September 2024. Over the past year, it has increased by +$30.41 million (+24.28%). ALVR TTM CFO is now -4698.84% below its all-time high of -$1.98 million, reached on 31 March 2019.ALVR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALVR Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.4% | +75.5% | +24.3% |
| 3 y3 years | -104.7% | +76.8% | +4.5% |
| 5 y5 years | -6505.1% | -31.8% | -740.5% |
ALVR Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -104.7% | +12.4% | at high | +81.8% | at high | +33.2% |
| 5 y | 5 years | -6505.1% | +12.4% | -31.8% | +81.8% | -740.5% | +33.2% |
| alltime | all time | -6505.1% | +12.4% | -326.9% | +81.8% | -4698.8% | +33.2% |
AlloVir Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.44 M(-25.4%) | -$94.87 M(-21.5%) |
| June 2024 | - | -$11.32 M(-74.5%) | -$120.91 M(-11.6%) |
| Mar 2024 | - | -$44.38 M(+44.4%) | -$136.71 M(+9.9%) |
| Dec 2023 | -$124.45 M(-12.4%) | -$30.73 M(-10.9%) | -$124.45 M(-0.7%) |
| Sept 2023 | - | -$34.48 M(+27.1%) | -$125.29 M(-0.5%) |
| June 2023 | - | -$27.12 M(-15.6%) | -$125.94 M(-1.4%) |
| Mar 2023 | - | -$32.12 M(+1.7%) | -$127.69 M(-10.1%) |
| Dec 2022 | -$142.05 M(+33.6%) | -$31.57 M(-10.1%) | -$142.05 M(+2.5%) |
| Sept 2022 | - | -$35.13 M(+21.6%) | -$138.55 M(-0.9%) |
| June 2022 | - | -$28.88 M(-37.9%) | -$139.86 M(+4.5%) |
| Mar 2022 | - | -$46.48 M(+65.6%) | -$133.87 M(+25.9%) |
| Dec 2021 | -$106.32 M | -$28.07 M(-23.0%) | -$106.32 M(+7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$36.44 M(+59.2%) | -$99.34 M(+22.7%) |
| June 2021 | - | -$22.89 M(+20.9%) | -$80.96 M(+17.0%) |
| Mar 2021 | - | -$18.93 M(-10.3%) | -$69.19 M(+13.8%) |
| Dec 2020 | -$60.81 M(+201.7%) | -$21.09 M(+16.8%) | -$60.81 M(+25.2%) |
| Sept 2020 | - | -$18.06 M(+62.4%) | -$48.59 M(+31.6%) |
| June 2020 | - | -$11.12 M(+5.5%) | -$36.93 M(+28.6%) |
| Mar 2020 | - | -$10.54 M(+18.9%) | -$28.72 M(+42.5%) |
| Dec 2019 | -$20.16 M(-1137.3%) | -$8.87 M(+38.5%) | -$20.16 M(+78.6%) |
| Sept 2019 | - | -$6.40 M(+120.3%) | -$11.29 M(+131.1%) |
| June 2019 | - | -$2.91 M(+47.0%) | -$4.88 M(+147.0%) |
| Mar 2019 | - | -$1.98 M | -$1.98 M |
| Dec 2018 | $1.94 M | - | - |
FAQ
- What is AlloVir annual cash flow from operations?
- What is the all time high annual CFO for AlloVir?
- What is AlloVir annual CFO year-on-year change?
- What is AlloVir quarterly cash flow from operations?
- What is the all time high quarterly CFO for AlloVir?
- What is AlloVir quarterly CFO year-on-year change?
- What is AlloVir TTM cash flow from operations?
- What is the all time high TTM CFO for AlloVir?
- What is AlloVir TTM CFO year-on-year change?
What is AlloVir annual cash flow from operations?
The current annual CFO of ALVR is -$124.45 M
What is the all time high annual CFO for AlloVir?
AlloVir all-time high annual cash flow from operations is $1.94 M
What is AlloVir annual CFO year-on-year change?
Over the past year, ALVR annual cash flow from operations has changed by +$17.60 M (+12.39%)
What is AlloVir quarterly cash flow from operations?
The current quarterly CFO of ALVR is -$8.44 M
What is the all time high quarterly CFO for AlloVir?
AlloVir all-time high quarterly cash flow from operations is -$1.98 M
What is AlloVir quarterly CFO year-on-year change?
Over the past year, ALVR quarterly cash flow from operations has changed by +$26.04 M (+75.52%)
What is AlloVir TTM cash flow from operations?
The current TTM CFO of ALVR is -$94.87 M
What is the all time high TTM CFO for AlloVir?
AlloVir all-time high TTM cash flow from operations is -$1.98 M
What is AlloVir TTM CFO year-on-year change?
Over the past year, ALVR TTM cash flow from operations has changed by +$30.41 M (+24.28%)